Otsuka's DELTYBA has treated more than 60,000 cases of tuberculosis since 2016
Register to read the full analysis —or— Upgrade to access more features
#Tuberculosis
#good health
#R&D
#drug development
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.